ResearcherUniversity of MichiganActive in the last 2 years

Steven J. Katz

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-1151-861X; OpenAlex author ID A5027207939; NIH RePORTER profile ID 1972398. Sources: OpenAlex.

Their work

Papers: 1
Trials: 0
Grants: 1
Labs led: 0
Collaborators: 4

Papers, trials and grants by year

2025: 1 paper · 2026: 1 grant

Papers 1

Breast, Colorectal, and Pancreatic Cancer Mortality With Pathogenic Variants in ATM, CHEK2, or PALB2. Co-author DOI 10.1200/jco-24-02442 ↗

Grants 1

Personalizing genetic test results management and outcomes after diagnosis of cancer: the Georgia-California SEER Genelink Study R01CA283207 ↗

Closest collaborators

The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Allison W. Kurian · 1 shared paper, 1 shared grant, 2025–2026 · strength 1.52
- Grant Personalizing genetic test results management and outcomes after diagnosis of cancer: the Georgia-California SEER Genel… R01CA283207 ↗
- Paper Breast, Colorectal, and Pancreatic Cancer Mortality With Pathogenic Variants in ATM, CHEK2, or PALB2. DOI 10.1200/jco-24-02442 ↗
Kevin C. Ward · 1 shared paper, 2025 · strength 0.26
- Paper Breast, Colorectal, and Pancreatic Cancer Mortality With Pathogenic Variants in ATM, CHEK2, or PALB2. DOI 10.1200/jco-24-02442 ↗
Christine Marie Veenstra · 1 shared paper, 2025 · strength 0.26
- Paper Breast, Colorectal, and Pancreatic Cancer Mortality With Pathogenic Variants in ATM, CHEK2, or PALB2. DOI 10.1200/jco-24-02442 ↗
Lihua Liu · 1 shared paper, 2025 · strength 0.26
- Paper Breast, Colorectal, and Pancreatic Cancer Mortality With Pathogenic Variants in ATM, CHEK2, or PALB2. DOI 10.1200/jco-24-02442 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.